8
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Circumvention of Drug Resistance in Cisplatin-resistant Sublines of the Human Squamous Carcinoma Cell Line HLac 79 in Vitro and in Vivo

Pages 797-806 | Received 23 Jul 1990, Accepted 21 Sep 1990, Published online: 08 Jul 2009

References

  • Choksi A J, Dimery I W, Hong WK. Adjuvant chemotherapy of head and neck cancer: the past, the present, the future. Sem Oncol 1988; 15: 45–59
  • Bier H, Bergler W, Mickisch G, Weseh H, Ganzer U. Establishment and characterization of cisplatin-resistam sublines of the human squamous carcinoma cell line HLac 79. Acta Otolaryngol (Stockh) 1990; 110: 466–73
  • Meister A. Novel drugs that affect glutathione metabolism. Mechanisms of drug resistance in neoplastic cells, A Kraker. Academic Press, London 1988; 99–125
  • Tsuruo T. Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 1988; 79: 285
  • Deuchars K L, Ling V. P-Glycoprotein and multidrug resistance in cancer chemotherapy. Sem Oncol 1989; 16: 156–65
  • Ikeda H, Nakano G, Nagashima K. Verapamil enhancement of antitumor effect of cis-diam-minedichloroplatinum (II) in nude mouse-grown human neuroblastoma. Cancer Res 1987; 47: 231–4
  • Onoda I M, Nelson K K, Taylor I D, Honn KV. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diammine-dichloroplatinum (II). Cancer Res 1989; 49: 2844–50
  • Twentyman PR. Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins. Br J Cancer 1988; 57: 254–8
  • Eastman A, Schulte N, Scheibani N, Sorensen CM. Mechanisms of resistance to platinum drugs. Platinum and other metal coordination compounds in cancer chemotherapy, M Nicolini. Martinus Nijhoff, Boston 1988; 178
  • Zenner H P, Lehner W, Herrmann IF. Establishment of cell lines from larynx and submandibular gland carcinoma. Arch Otorhinolaryngol 1979; 225: 269–77
  • Zenner H P, Herrmann I F, Brenner W, Stahl-Mauge C. Head and neck carcinoma models. in vivo reproduction in athymic mice and in vitro culture. Acta Otolaryngol (Stockh) 1983; 95: 371–81
  • Volm M, Bak M, Efferth T, Mattern J. Induced multidrug resistance in murine leukemia L 1210 and associated changes in a surface-membrane glycoprotein. J Cancer Res Clin Oncol 1989; 115: 17–24
  • Bier H, Bergler W, Mende S, Ganzer U. Glutathione content and y-glutamyltranspeptidase activity in squamous cell head and neck cancer xenografts. Arch Otorhinolaryngol 1988; 245: 166–9
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
  • Ozols R F, Louie K G, Plowman J. Enhanced Melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 1987; 36: 147–53
  • Crook T R, Souhami R L, Whyman G D, McLean A EM. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res 1986; 46: 5035–8
  • Hansson J, Edgren M, Ehrsson H. Effect of D, L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Cancer Res 1988; 48: 19–26
  • Hamilton T C, Winker M A, Louie KG. Augmentation of adriamycin melphalan and cisplatin cytotoxicity in drug-resistant and-sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 1985; 34: 2583–6
  • Lai G M, Young R C, Hamilton T C, Ozols RF. Modulation of DNA repair by buthionine sulfoximine in a cisplatin resistant human ovarian cancer cell line. Proc AACR 1989; 30: 490
  • Milroy R, Connery L, Hutcheon A. A randomized trial of verapamil in addition to chemotherapy for small cell lung cancer. Thorax 1987; 42: 209
  • Osieka R, Seeber S, Pannenbacker R. Enhancement of etoposide-induced cytotoxicity by cyclosporin A. Cancer Chemother Pharmacol 1986; 18: 198–202
  • Skapek S X, Colvin O M, Griffith OW. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts. Biochem Pharmacol 1988; 37: 4313–17
  • Friedman H S, Colvin O M, Griffith OW. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion. J Natl Cancer Inst 1989; 81: 524–7
  • Tomashefsky P, Astor M, White RD. Relationship between thiol depletion and chemosensitiza-tion in a transplantable murine bladder tumour. J Natl Cancer Inst 1985; 74: 1233–7
  • Smith A C, Page J G, Carlton BD. Preclinical toxicology and pharmacokinetic studies of buthionine sulfoximine in Beagle dogs. Proc AACR 1987; 28: 440

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.